Prevalence of jaundice among new born baby

1. PREVALENCE OF JAUNDICE
AMONG NEW BORN BABIES IN PLATEAU SPECIALIST HOSPITALAND JUTH IN PATEAU
STATE
PROJECT PROPOSAL SEMINAR
BY
ENDURANCE IRMIYA ND/SLT/2021/1167
JACOB ZIBEON YOILA ND/SLT/2021/1339
TERZUNGWE FAITH ND/SLT/2021/1163
JOSEPH M. PIOR ND/SLT/2021/1173
AKULAM INNOCENT EMMANUEL ND/SLT/2021/1165
DEPARTMENT OF SCIENCE LABORATORY TECHNOLOGY,
FEDERAL COLLEGE OF ANIMAL HEALT AND PRODUCTION TECHNOLOGY, VOM
SUPERVISOR:
MR. BELLO OWOLABI
APRIL, 2023

2. INTRODUCTION
Jaundice is a common condition in newborns, characterized by the
yellowing of the skin and whites of the eyes due to the accumulation of
bilirubin in the blood Ansong-Assoku, et al 2022. Newborn jaundice is also
called neonatal hyperbilirubinemia. The causes is often an immature liver,
infection, medication or blood disorders may cause more serious cases.
More than 100 thousand cases per year. Jaundice usually clears up within
2 weeks in formula-fed babies. It may last for more than 2 to 3 weeks.
Phototherapy is treatment with a special type of light(not sunlight)
It is estimated that 60% of full-term and 80% of premature babies develop
jaundice within the first week of life (American Academy of Pediatrics
Subcommittee on Hyperbilirubinemia, 2004).

3. STATEMENT OF THE PROBLEM
Despite the high prevalence of neonatal jaundice, there is a lack of
comprehensive data on the incidence and risk factors for the
condition among babies born in Plateau State.
This information is essential for the development of appropriate
prevention and management strategies for neonatal jaundice in the
state.
Therefore, this study aims to determine the prevalence and risk
factors for neonatal jaundice among babies born in Plateau State.

4. AIM AND OBJECTIVES
Aim
• The aim of this study is to determine the prevalence and risk factors
for neonatal jaundice among babies born in Plateau State.
Objectives
• To determine the prevalence of neonatal jaundice among babies
born in Plateau Specialist Hospital and JUTH.
• To identify the risk factors associated with neonatal jaundice in the
study population.
• To assess the knowledge and practices of healthcare workers
regarding the prevention and management of neonatal jaundice in
Plateau State.

5. Significance of the Study
This study will provide valuable information on the prevalence
and risk factors for neonatal jaundice in Plateau State.
The findings will be useful for healthcare professionals in the state
in the development of appropriate prevention and management
strategies for the condition.
Additionally, the study will contribute to the body of knowledge
on neonatal jaundice in Nigeria and will provide a basis for further
research in this area.

6. METHODOLOGY
Study Design
• This study will be a cross-sectional survey conducted in two selected
healthcare facilities in Plateau State. The study design is appropriate for
determining the prevalence and risk factors for neonatal jaundice in the
study population.
Study Population and Sampling Technique
• The study population will consist of babies born in selected healthcare
facilities in Plateau State. A total sample size of 100 babies will be
selected, 50 samples from each healthcare provider either through the
record in the hospital or mothers of the affected babies.

7. Data Collection
Data will be collected using a structured questionnaire administered to
the mothers/care-givers of the babies.
The questionnaire will be pretested in a healthcare facility in a different
LGA from the study population.
The questionnaire will include questions on demographic
characteristics, pregnancy and delivery history, neonatal characteristics,
and knowledge and practices of healthcare workers regarding the
prevention and management of neonatal jaundice.

8. Data Analysis
Data will be entered into EpiData software and analyzed using Stata
software. Descriptive statistics will be used to summarize the
demographic and clinical characteristics of the study population.
The knowledge and practices of healthcare workers regarding the
prevention and management of neonatal jaundice will be analyzed
using descriptive statistics

9. Ethical Considerations
Ethical approval will be obtained from the Plateau State
Ministry of Health and the Institutional Review Board of the
University of Jos Teaching Hospital.
Informed consent will be obtained from the
mothers/caregivers of the babies before enrollment in the
study.
Confidentiality and anonymity of the study participants will
be ensured throughout the study.

10. REFERENCES
American Academy of Pediatrics Subcommittee on Hyperbilirubinemia.
(2004). Management of hyperbilirubinemia in the newborn infant 35
or more weeks of gestation. Pediatrics, 114(1), 297-316.
Bhutani, V. K., Johnson, L., Sivieri, E. M. (2006). Predictive ability of a
predischarge hour-specific serum bilirubin for subsequent significant
hyperbilirubinemia in healthy term and near-term newborns.
Pediatrics, 118, 5–14.
Bhutani, V. K., Stark, A. R., Lazzeroni, L. C., Poland, R., Gourley, G. R., &
Kazmierczak, S. (2013). Predischarge screening for severe neonatal
hyperbilirubinemia identifies infants who need phototherapy. The
Journal of Pediatrics, 162(3), 477-482.
Maisels, M. J., Newman, T. B. (2019). Neonatal jaundice. In: Martin RJ,
Fanaroff AA, Walsh MC, editors. Fanaroff and Martin’s Neonatal-
Perinatal Medicine. 11th ed. Philadelphia: Elsevier; 2019. p. 743–79.

11. THANK YOU FOR LISTENING